论文部分内容阅读
本文对500例不同肝病患者血清CG、HA、SF进行联合测定,并将结果加以分析对比发现以上三种检验指标对肝病的诊断有明显的价值,现报告如下。 对象和方法 一、对象:500例(男294,女206)肝病患者均为我院收治门诊和住院病人。年龄18～68岁。临床诊断按1984年病毒性肝炎学术会议修订诊断分型标准诊为AH 77例;CPH 116例;CAH 137例;LA 128例;LC 42例。以上病例均经快速穿刺法肝活检确诊。同期取200名(男118,女82)健康人作对照,平均年龄34.5岁。 二、方法:CG、HA、SF的检测方法均用放射免疫法。试齐盒由中国原子能研究院提供,按说明书操作。 结果 一、肝病组和正常对照组血清CG、HA、SF检测结果比较:见表1。
In this paper, 500 cases of different liver disease serum CG, HA, SF joint determination, and the results were analyzed and compared to find the above three indicators of liver disease diagnosis of significant value, are as follows. Subjects and methods First, the object: 500 cases (male 294, female 206) liver disease patients were admitted to our hospital outpatient and inpatient. Age 18 ~ 68 years old. According to the 1984 diagnosis of viral hepatitis meeting diagnostic criteria for diagnosis of AH 77 cases; CPH 116 cases; CAH 137 cases; LA 128 cases; LC 42 cases. The above cases were confirmed by rapid biopsy of liver biopsy. Over the same period to take 200 (male 118, female 82) healthy people as controls, with an average age of 34.5 years. Second, methods: CG, HA, SF detection methods are used radioimmunoassay. Qi test box provided by China Institute of Atomic Energy, according to instructions. Results a, liver disease group and normal control group serum CG, HA, SF test results comparison: Table 1.